We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Cutting‑Edge Non‑Invasive System Revolutionizes Point-of-Care Hospital Diagnostics

By HospiMedica International staff writers
Posted on 11 Jun 2025

Diabetic neuropathy affects nearly half of all diabetes patients, often leading to pain, numbness, and complications in the cardiovascular, digestive, and urinary systems. More...

Compounding the risk, cardiovascular diseases and peripheral artery disease (PAD) are more common in this group due to factors like hypertension and atherosclerosis. Now, a new technology offers an integrated, non-invasive approach that streamlines diagnostics, improves accuracy, and enhances clinical efficiency.

Brina Medical (Miami, FL, USA) has introduced the CMAT Advantage—a next-generation point-of-care diagnostic system designed to help healthcare providers keep pace with rising chronic disease rates. This advanced, non-invasive device combines three key tests into one seamless procedure: the Ankle-Brachial Index (ABI) for PAD detection, Autonomic Nervous System (ANS) assessment for neuropathies, and Sudomotor Function Testing for small fiber nerve damage.

The device’s TM-ABI technology precisely evaluates peripheral arterial health, while dynamic ANS tests, like postural changes and deep breathing, help detect autonomic dysfunction. Sudomotor testing uses galvanic skin response to identify early nerve damage through sweat gland activity. Powered by proprietary AI and real-time decision support tools, the CMAT Advantage delivers actionable insights instantly. Its integration into routine workflows enables early disease detection, faster interventions, and reduced hospitalizations—empowering providers to elevate patient care and operational performance.

"Hospitals and healthcare providers face immense pressure to achieve better outcomes with fewer resources — and that's exactly where the CMAT Advantage delivers," said Brent Pearson, CEO of Brina Medical. "Designed for the realities of modern care — high volume, limited time, and maximum stakes — CMAT Advantage gives care teams a powerful ally to detect chronic disease early, act decisively, and improve lives before complications escalate. This isn't just a diagnostic device — it's a catalyst for system-wide transformation."

Related Links:
Brina Medical 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Ureteral Dilatation Balloon
Dornier Equinox
New
Measuring Rod
seca 233
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.